Aging
Navigate
Submit an Article
Research Paper|Volume 12, Issue 24|pp. 25767–25777
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells
Back to articleFigure 7(7 of 7)
100%
Figure 7
Figure 7.Anti-tumor activity of ZnO-NPs in vivo. (A) image of subcutaneous xenograft tumors.(B) Tumor weight. * P< 0.05 vs. Control.